Studying temocillin in children with kidney infection
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies how the antibiotic temocillin works in children with a kidney infection caused by certain bacteria. It may help doctors give the right dose for better treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between birth and 15 years old.
- They must have a fever and a urine infection caused by certain bacteria (gram-negative rods).
- They need to stay in the hospital for at least 48 hours.
- We must have permission from you, their legal guardian.
- Your child cannot have severe sepsis, a severe kidney problem, or an allergy to beta-lactam antibiotics (like penicillin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an antibiotic called temocillin works as well as standard treatment for gonorrhea that has no symptoms. You may qualify if you've tested positive for gonorrhea but don't have signs of infection.
This trial tests whether giving antibiotics through a vein for 3 days works as well as giving 3 days through a vein followed by 7 days by mouth for a first urinary tract infection (kidney infection). It may help your child recover safely while possibly reducing longer IV treatment.
This study compares two antibiotics—piperacillin-tazobactam or temocillin—to treat severe ICU infections caused by certain hard-to-treat gut bacteria (ESBL). It may help patients avoid the use of carbapenem antibiotics like meropenem when the bacteria are susceptible.
This study tests a new antibiotic for children with difficult-to-treat urinary tract infections (UTIs). The medicine is given through an IV and may help when other antibiotics haven't worked.
This trial tests a single dose of an investigational antibiotic called gepotidacin in children aged 2 to 12 who have a bacterial infection or are taking antibiotics to prevent one. The goal is to see how the medicine works in young patients.
This trial compares giving a long, continuous infusion versus standard short infusions of certain antibiotics (beta-lactams) to children with sepsis in intensive care. The goal is to find which method works better and is safer.
Hear when a new Pyelonephritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.